NCI Will Get $1.3 Billion, But Only If Congress Fends Off GRH Cuts, Reprogramming For Drug War
In Brief: Kea, Montes Leave DCPC; Smart Heads Early Detection Branch; Costlow Special Assistant
DCPC Board Asks More Money For Cancer Control In Centers, Urges Support Of Measure On Employment Discrimination
NCI Intends To Extend OSCC Two More Years
Prostate Ultrasound Markers Concepts Approved by BSC
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
